Merck & Co Q2 Adj. EPS $1.31 Misses $1.44 Estimate, Sales $11.40B Miss $11.54B Estimate
Merck & Co (NYSE:MRK) reported quarterly earnings of $1.31 per share which missed the analyst consensus estimate of $1.44 by 9.03 percent. This is a 4.38 percent decrease over earnings of $1.37 per share from the same